Skip to main content
SpringerLink
Log in

“Salvage treatment” for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal

  • Letter
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F et al (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795

    Article  CAS  PubMed  Google Scholar 

  2. Wertheim H, Van Nguyen K, Hara GL, Gelband H, Laxminarayan R, Mouton J et al (2013) Global survey of polymyxin use: a call for international guidelines. J Glob Antimicrob Resist 1:131–134

    Article  PubMed  PubMed Central  Google Scholar 

  3. Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP et al (2011) Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 55:3284–3294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Polymyxin Article-31 referral—annex II. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Polymyxin-containing_medicines/human_referral_000383.jsp&mid=WC0b01ac05805c516f. Assessed Jan 2017

  5. Nation RL, Garonzik SM, Li J, Thamlikitkul V, Giamarellos-Bourboulis EJ, Paterson DL et al (2016) Updated United States and European dose recommendations for intravenous colistin: how do they perform? Clin Infect Dis 62:552–558

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The study was designed and performed by the Study Group “Infections in Critically Ill Patients” (ESGCIP), of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Investigators are listed in S7 Table, Electronic supplement. A preliminary analysis of the results was presented as a Poster (No 4204) in the 24th ECCMID 2014, 10–13 May 2014, Barcelona, Spain.

Author information

Authors and Affiliations

  1. 4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Attikon University General Hospital of Athens, Athens, Greece

    Garyfallia Poulakou

  2. Department of Critical Care, University Hospital Attikon, Medical School, University of Athens, Athens, Greece

    Dimitrios K. Matthaiou & George Dimopoulos

  3. Infectious Diseases Division, Azienda Ospedaliera Universitaria Santa Maria Misericordia Hospital, Udine, Italy

    Matteo Bassetti

  4. Principal Coordinator, ID-IRI, Ankara, Turkey

    Hakan Erdem

  5. Infectious Diseases Department, Buenos Aires University, Buenos Aires, Argentina

    Daniel J. Curcio

  6. 9 rue de la Terrasse, 94000, Creteil, France

    Jean Carlet

  7. Intensive Care Services, Royal Brisbane and Women’s Hospital, Herston, Brisbane, QLD, 4029, Australia

    Jeffrey Lipman

  8. Anaesthesiology and Critical Care, School of Medicine, The University of Queensland, Brisbane, Australia

    Jeffrey Lipman

  9. Faculty of Health, Queensland University of Technology, Brisbane, Australia

    Jeffrey Lipman

  10. The George Institute for Global Health, University of Sydney, Sydney, Australia

    Jeffrey Lipman

  11. University of Witwatersrand, Johannesburg, South Africa

    Jeffrey Lipman

  12. Université Paris Diderot/Hopital Bichat-Réanimation Medicale et Des Maladies Infectieuses, 46 rue Henri Huchard, 75018, Paris, France

    Jean-François Timsit

  13. UMR 1137-IAME Team 5-DeSCID: Decision SCiences in Infectious Diseases, Control and Care, Inserm/Univ Paris Diderot, Sorbonne Paris Cité, 75018, Paris, France

    Jean-François Timsit

  14. 6th Department of Internal Medicine, Hygeia Hospital, Marousi, Athens, Greece

    Helen Giamarellou

  15. National and Kapodistrian University of Athens, Medical School, Attikon University General Hospital of Athens, Athens, Greece

    Angelos Arfaras-Melainis

  16. CIBERES, Universitat Autonoma de Barcelona, Barcelona, Spain

    Jordi Rello

Authors
  1. Garyfallia Poulakou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dimitrios K. Matthaiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matteo Bassetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hakan Erdem
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. George Dimopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniel J. Curcio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jean Carlet
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jeffrey Lipman
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jean-François Timsit
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Helen Giamarellou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Angelos Arfaras-Melainis
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jordi Rello
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

The ESGCIP Investigators

Corresponding author

Correspondence to Garyfallia Poulakou.

Ethics declarations

Funding

This study has not received any funding.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Additional information

The ESGCIP Investigators are given in acknowledgements.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poulakou, G., Matthaiou, D.K., Bassetti, M. et al. “Salvage treatment” for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal. Intensive Care Med 43, 1164–1166 (2017). https://doi.org/10.1007/s00134-017-4796-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-017-4796-y

Keywords

Search

Navigation